We are live on ! Find out more
NICM

Neo Ivy Capital Management Portfolio holdings

AUM $379M
1-Year Est. Return 28.34%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+28.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$379M
AUM Growth
-$254M
Cap. Flow
-$238M
Cap. Flow %
-62.8%
Top 10 Hldgs %
10.75%
Holding
527
New
191
Increased
45
Reduced
79
Closed
212

Top Sells

Rank Stock Value
1
DLB icon
Dolby
DLB
+$7.58M
2
WELL icon
Welltower
WELL
+$7.56M
3
ROIV icon
Roivant Sciences
ROIV
+$7.12M
4
TTMI icon
TTM Technologies
TTMI
+$6.96M
5
WRBY icon
Warby Parker
WRBY
+$6.87M

Sector Composition

Rank Sector Weight
1 Technology 23.02%
2 Healthcare 15.27%
3 Consumer Discretionary 12.84%
4 Industrials 11.71%
5 Financials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HII icon
76
Huntington Ingalls Industries
HII
$12.8B
$2.01M 0.53%
+5,279
New +$2.18M
FTV icon
77
Fortive
FTV
$18.6B
$1.91M 0.5%
+34,574
New +$1.94M
CPNG icon
78
Coupang
CPNG
$29.2B
$1.9M 0.5%
+100,503
New +$1.97M
BE icon
79
Bloom Energy
BE
$64.6B
$1.86M 0.49%
13,711
-20,246
-60% -$2.97M
CLMT icon
80
Calumet Specialty Products
CLMT
$3.44B
$1.85M 0.49%
+51,435
New +$1.33M
NKE icon
81
Nike
NKE
$61.9B
$1.83M 0.48%
34,646
+11,496
+50% +$697K
ADMA icon
82
ADMA Biologics
ADMA
$2.22B
$1.8M 0.47%
199,687
+130,545
+189% +$2.06M
ROIV icon
83
Roivant Sciences
ROIV
$26.2B
$1.78M 0.47%
64,106
-277,248
-81% -$7.12M
OZK icon
84
Bank OZK
OZK
$5.61B
$1.78M 0.47%
+38,695
New +$1.82M
JNJ icon
85
Johnson & Johnson
JNJ
$625B
$1.75M 0.46%
+7,178
New +$1.67M
GMED icon
86
Globus Medical
GMED
$11.2B
$1.74M 0.46%
+20,206
New +$1.81M
T icon
87
AT&T
T
$163B
$1.72M 0.45%
59,286
-178,151
-75% -$4.76M
AAL icon
88
American Airlines Group
AAL
$10.6B
$1.7M 0.45%
157,994
-172,336
-52% -$2.28M
HPQ icon
89
HP
HPQ
$27.5B
$1.69M 0.45%
88,174
-6,528
-7% -$127K
GAP
90
The Gap Inc
GAP
$7.37B
$1.69M 0.45%
69,830
+54,190
+346% +$1.43M
CNX icon
91
CNX Resources
CNX
$5.2B
$1.67M 0.44%
43,449
+15,959
+58% +$623K
CWEN icon
92
Clearway Energy Class C
CWEN
$6.7B
$1.65M 0.44%
42,028
+25,095
+148% +$938K
APH icon
93
Amphenol
APH
$209B
$1.62M 0.43%
12,799
+4,818
+60% +$678K
BMY icon
94
Bristol-Myers Squibb
BMY
$132B
$1.56M 0.41%
+25,660
New +$1.5M
AIG icon
95
American International
AIG
$41.3B
$1.56M 0.41%
20,677
+281
+1% +$21.5K
RARE icon
96
Ultragenyx Pharmaceutical
RARE
$2.55B
$1.54M 0.41%
+73,601
New +$1.66M
M icon
97
Macy's
M
$6.68B
$1.53M 0.4%
84,495
-78,777
-48% -$1.59M
KVUE icon
98
Kenvue
KVUE
$36.9B
$1.5M 0.4%
+86,981
New +$1.55M
MGM icon
99
MGM Resorts International
MGM
$11.2B
$1.5M 0.4%
40,501
-58,874
-59% -$2.1M
GBCI icon
100
Glacier Bancorp
GBCI
$6.35B
$1.5M 0.39%
+33,477
New +$1.58M

Similar funds

Neo Ivy Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Neo Ivy Capital Management held 527 positions worth $379M, down 40% from $633M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Neo Ivy Capital Management withdrew a net $238M in Q1 2026, closing 212 positions and reducing 79 holdings. Its most notable exit was Dolby, an estimated $7.58M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Neo Ivy Capital Management opened a new position in Credo Technology Group worth $3.79M.

  • Neo Ivy Capital Management's largest Q1 2026 buy was Credo Technology Group: 40,398 shares worth $3.79M.
  • Neo Ivy Capital Management added most to Gartner in Q1 2026, an estimated $2.71M increase.
  • Neo Ivy Capital Management's biggest Q1 2026 reduction was Roivant Sciences, cutting an estimated $7.12M.
  • Neo Ivy Capital Management fully exited Dolby in Q1 2026, selling an estimated $7.58M.
  • Neo Ivy Capital Management's ten largest holdings make up 11% of its $379M portfolio in Q1 2026.
  • Neo Ivy Capital Management opened 191 new positions and closed 212 in Q1 2026.
  • Neo Ivy Capital Management's portfolio value fell 40% quarter-over-quarter to $379M.

Based on Neo Ivy Capital Management's 13F filing for Q1 2026, filed 15 May 2026.